Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2025-12-25 @ 2:28 PM
NCT ID:
NCT00865566
Group ID:
EG001
Title:
Placebo
Description:
Participants will receive a recombinant DNA plasmid vaccine placebo injection at study entry and on Days 28 and 56, followed by a recombinant adenoviral serotype vector vaccine placebo injection on Day 168. As of April 2013, all vaccinations in this study have been stopped.
DNA vaccine placebo: 1 mL IM via Biojector® in either deltoid
HIV-1 recombinant adenovirus vaccine placebo: 1 mL administered IM by needle and syringe in either deltoid
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
95
Serious Number At Risk:
1251
Other Number Affected:
828
Other Number At Risk:
1251
Study:
NCT00865566
Results Section:
NCT00865566
Adverse Events Module:
NCT00865566